scholarly journals Theranostic Applications of Nanomaterials for Ophthalmic Applications

2021 ◽  
Vol 2 (3) ◽  
Author(s):  
Kaushal Divya ◽  
Pathak Yashwant V. ◽  
Sneed Kevin B.
Keyword(s):  
Conventional Medicine ◽  
Age Related Macular Degeneration ◽  
Control Treatment ◽  
Biological Interaction ◽  
Ocular Diseases ◽  
Treatment And Prevention ◽  
Age Related ◽  
New Form ◽  
Theranostic Applications ◽  
And Personalized Medicine

The development of theranostic applications of nanomaterials has presented researchers with a new form of diagnosing and treating diseases, such as cancer, Diabetic Retinopathy, and Age-Related Macular Degeneration. Theranostic have allowed for a bridge between conventional medicine and personalized medicine with the use of nanomaterials. The applications of nanomaterials within medicine (nanomedicine) have changed the diagnosis, monitoring, control, treatment, and prevention of diseases. The effects of the biological interaction of nanomaterials within the human body must be examined further to understand the efficacy, toxicity, and biodistribution. The use of theranostic application of nanomaterials has gained attention in the field of Ophthalmology. The use of theranostic nanomaterials to reduce current treatments, complications, diagnosis, reduce the effects and treat a visually threatening disease is appealing. The benefit of treating ocular diseases with theranostic will allow for better visibility and targeted treatment.

Oxidative Stress, Ocular Disease and Diabetes Retinopathy

2019 ◽  
Vol 24 (40) ◽  
pp. 4726-4741 ◽  
Author(s):  
Orathai Tangvarasittichai ◽  
Surapon Tangvarasittichai
Keyword(s):  
Oxidative Stress ◽  
Dna Damage ◽  
Cell Death ◽  
Protein Modification ◽  
Morphological Changes ◽  
Corneal Dystrophy ◽  
Age Related Macular Degeneration ◽  
Ocular Diseases ◽  
Retinal Light Damage ◽  
Age Related

Background: Oxidative stress is caused by free radicals or oxidant productions, including lipid peroxidation, protein modification, DNA damage and apoptosis or cell death and results in cellular degeneration and neurodegeneration from damage to macromolecules. Results: Accumulation of the DNA damage (8HOdG) products and the end products of LPO (including aldehyde, diene, triene conjugates and Schiff’s bases) were noted in the research studies. Significantly higher levels of these products in comparison with the controls were observed. Oxidative stress induced changes to ocular cells and tissues. Typical changes include ECM accumulation, cell dysfunction, cell death, advanced senescence, disarrangement or rearrangement of the cytoskeleton and released inflammatory cytokines. It is involved in ocular diseases, including keratoconus, Fuchs endothelial corneal dystrophy, and granular corneal dystrophy type 2, cataract, age-related macular degeneration, primary open-angle glaucoma, retinal light damage, and retinopathy of prematurity. These ocular diseases are the cause of irreversible blindness worldwide. Conclusions: Oxidative stress, inflammation and autophagy are implicated in biochemical and morphological changes in these ocular tissues. The development of therapy is a major target for the management care of these ocular diseases.

scholarly journals The microbiome and ophthalmic disease

2018 ◽  
Vol 244 (6) ◽  
pp. 419-429 ◽  
Author(s):  
Adam D Baim ◽  
Asadolah Movahedan ◽  
Asim V Farooq ◽  
Dimitra Skondra
Keyword(s):  
Ocular Surface ◽  
Open Angle Glaucoma ◽  
Age Related Macular Degeneration ◽  
Therapeutic Interventions ◽  
Gastrointestinal Microbiota ◽  
Treatment And Prevention ◽  
Age Related ◽  
Microbiome Research ◽  
Ophthalmic Diseases ◽  
Ophthalmic Disease

Progress in microbiome research has accelerated in recent years. Through the use of 16S rRNA assays and other genomic sequencing techniques, researchers have provided new insights about the communities of microorganisms that inhabit human and animal hosts. There is mounting evidence about the importance of these ‘microbiotas’ in a wide variety of disease states, suggesting potential targets for preventative and therapeutic interventions. Until recently, however, the microbiome received relatively little attention in ophthalmology. This review explores emerging research on the roles that ocular and extraocular microbiotas may play in the pathogenesis and treatment of ophthalmic diseases. These include diseases of the ocular surface as well as autoimmune uveitis, age-related macular degeneration, and primary open angle glaucoma. Many questions remain about the potential impacts of microbiome research on the diagnosis, treatment, and prevention of ophthalmic disease. In light of current findings, we suggest directions for future study as this exciting area of research continues to expand. Impact statement This review describes a growing body of research on relationships between the microbiome and eye disease. Several groups have investigated the microbiota of the ocular surface; dysregulation of this delicate ecosystem has been associated with a variety of pro-inflammatory states. Other research has explored the effects of the gastrointestinal microbiota on ophthalmic diseases. Characterizing the ways these microbiotas influence ophthalmic homeostasis and pathogenesis may lead to research on new techniques for managing ophthalmic disease.

Cell-based therapy for ocular disorders: A promising frontier

2021 ◽  
Vol 16 ◽  
Author(s):  
Milad Ahani-Nahayati ◽  
Vahid Niazi ◽  
Alireza Moradi ◽  
Bahareh Pourjabbar ◽  
Reza Roozafzoon ◽  
...  
Keyword(s):  
Stem Cells ◽  
Wide Spectrum ◽  
Retinal Pigment ◽  
Age Related Macular Degeneration ◽  
Ocular Tissue ◽  
Ocular Diseases ◽  
Cell Based Therapy ◽  
Age Related ◽  
Ocular Disorders

: As the ocular disorders causing long-term blindness or optical abnormalities of the ocular tissue affect the quality of life of patients to a large extent, awareness of their corresponding pathogenesis and the earlier detection and treatment need more consideration. Though current therapeutics result in desirable outcomes, they do not offer an inclusive solution for development of visual impairment to blindness. Accordingly, stem cells, because of their particular competencies, have gained extensive attention for application in regenerative medicine of ocular diseases. In the last decades, a wide spectrum of stem cells surrounding mesenchymal stem/stromal cells (MSC), neural stem cells (NSCs), and embryonic/induced pluripotent stem cells (ESCs/iPSCs) accompanied by Müller glia, ciliary epithelia-derived stem cells, and retinal pigment epithelial (RPE) stem cells have been widely investigated to report their safety and efficacy in preclinical models and also human subjects. In this regard, in the first interventions, RPE cell suspensions were successfully utilized to ameliorate visual defects of the patients suffering from age-related macular degeneration (AMD) after subretinal transplantation. Herein, we will explain the pathogenesis of ocular diseases and highlight the novel discoveries and recent findings in the context of stem cell-based therapies in these disorders, focusing on the in vivo reports published during the last decade.

scholarly journals Saffron (Crocus sativus L.) in Ocular Diseases: A Narrative Review of the Existing Evidence from Clinical Studies

Nutrients ◽  
2019 ◽  
Vol 11 (3) ◽  
pp. 649 ◽  
Author(s):  
Rebekka Heitmar ◽  
James Brown ◽  
Ioannis Kyrou
Keyword(s):  
Clinical Studies ◽  
Wide Spectrum ◽  
Narrative Review ◽  
Age Related Macular Degeneration ◽  
Crocus Sativus ◽  
Ocular Diseases ◽  
Neuroprotective Effects ◽  
Age Related ◽  
Underlying Mechanisms ◽  
Crocus Sativus L

Saffron (Crocus sativus L.) and its main constituents, i.e., crocin and crocetin, are natural carotenoid compounds, which have been reported to possess a wide spectrum of properties and induce pleiotropic anti-inflammatory, anti-oxidative, and neuroprotective effects. An increasing number of experimental, animal, and human studies have investigated the effects and mechanistic pathways of these compounds in order to assess their potential therapeutic use in ocular diseases (e.g., in age related macular degeneration, glaucoma, and diabetic maculopathy). This narrative review presents the key findings of published clinical studies that examined the effects of saffron and/or its constituents in the context of ocular disease, as well as an overview of the proposed underlying mechanisms mediating these effects.

scholarly journals The burden of ocular diseases in an underdeveloped village in Southwest Sumba, Eastern Indonesia, 2016

2018 ◽  
Vol 26 (4) ◽  
pp. 277-85 ◽  
Author(s):  
Ratna Sitompul ◽  
Yeni D. Lestari ◽  
Simon Siregar ◽  
Asti Ayudianingrum ◽  
Isfiyanto Isfiyanto ◽  
...  
Keyword(s):  
Initial Step ◽  
Cross Sectional Study ◽  
Age Related Macular Degeneration ◽  
Ocular Diseases ◽  
Eye Care ◽  
Public Health Action ◽  
Cross Sectional ◽  
Eastern Indonesia ◽  
Care Services ◽  
Age Related

Background: Prevalence estimates of ocular diseases in a given district are important to plan the programs of eye care services. This study aimed to describe the burden of ocular diseases as an initial step in improving eye care services in underdeveloped areas in Indonesia.Methods: A cross-sectional study was performed among residents of Perobatang Village in Southwest Sumba district in July 2016. Eye examinations were conducted by ophthalmologists, and visual acuity was measured by optometrists. Participants were provided with appropriate treatment according to diagnosis. Surgical services were offered two months after the examination.Results: After eximining a total of 667 of 1,459 (46%) residents, the result showed that the most frequent ocular problems were presbyopia (30.8%), cataract (12.8%), refractive error (11.3%), and pterygium (10.7%). The proportion of myopia was 5.9%, hyperopia was 5.0%, and astigmatism was 2.2%. Moreover, the proportion of blindness was 10%. Cataract caused blindness in 44 participants. Other causes of blindness included age-related macular degeneration, retinopathy, optic atrophy, glaucoma, retinal detachment and trauma.Conclusion: The burden of ocular problems in Perobatang Village, Southwest Sumba, Eastern Indonesia was high. These findings showed the importance of public health action from local government and non-governmental organizations to improve eye care services in Southwest Sumba district.

Bruch’s membrane pathology: A mechanistic perspective

2020 ◽  
Vol 30 (6) ◽  
pp. 1195-1206 ◽  
Author(s):  
Aishwarya Murali ◽  
Subramanian Krishnakumar ◽  
Anuradha Subramanian ◽  
Sowmya Parameswaran
Keyword(s):  
Extracellular Matrix ◽  
Retinal Pigment Epithelium ◽  
Pigment Epithelium ◽  
Retinal Pigment ◽  
Vital Role ◽  
Age Related Macular Degeneration ◽  
Ocular Diseases ◽  
Bruch's Membrane ◽  
Bruch’S Membrane ◽  
Age Related

Bruch’s membrane, an extracellular matrix located between the retinal pigment epithelium and the choroid, plays a vital role as structural and functional support to the retinal pigment epithelium. Dysfunction of Bruch’s membrane in both age-related macular degeneration and other ocular diseases is caused mostly by extracellular matrix degeneration, deposit formation, and angiogenesis. Although these factors are dealt in greater detail with respect to the cells that are degenerated such as the retinal pigment epithelium and the endothelial cells, the pathology involving the Bruch’s membrane is often underrated. Since in most of the macular degenerations early degenerative changes are also observed in the Bruch’s membrane, addressing only the cellular component without the underlying membrane will not yield an ideal clinical benefit. This review aims to discuss the factors and the mechanisms affecting the integrity of the Bruch’s membrane, which would aid in developing an effective therapy for these pathologies.

scholarly journals A Systematic Review of Deep Learning Methods Applied to Ocular Images

2019 ◽  
Vol 30 (1) ◽  
pp. 9-26 ◽  
Author(s):  
Oscar Julian Perdomo Charry ◽  
Fabio Augusto González Osorio
Keyword(s):  
Deep Learning ◽  
Macular Degeneration ◽  
Clinical Signs ◽  
Age Related Macular Degeneration ◽  
Ocular Diseases ◽  
Learning Methods ◽  
Age Related ◽  
Box Models ◽  
The One

Artificial intelligence is having an important effect on different areas of medicine, and ophthalmology has not been the exception. In particular, deep learning methods have been applied successfully to the detection of clinical signs and the classification of ocular diseases. This represents a great potential to increase the number of people correctly diagnosed. In ophthalmology, deep learning methods have primarily been applied to eye fundus images and optical coherence tomography. On the one hand, these methods have achieved an outstanding performance in the detection of ocular diseases such as: diabetic retinopathy, glaucoma, diabetic macular degeneration and age-related macular degeneration.  On the other hand, several worldwide challenges have shared big eye imaging datasets with segmentation of part of the eyes, clinical signs and the ocular diagnostic performed by experts. In addition, these methods are breaking the stigma of black-box models, with the delivering of interpretable clinically information. This review provides an overview of the state-of-the-art deep learning methods used in ophthalmic images, databases and potential challenges for ocular diagnosis

scholarly journals Potential Therapeutic Candidates for Age-Related Macular Degeneration (AMD)

Cells ◽  
2021 ◽  
Vol 10 (9) ◽  
pp. 2483
Author(s):  
Sonali Nashine
Keyword(s):  
Macular Degeneration ◽  
Pigment Epithelium ◽  
Vascular Inflammation ◽  
Retinal Pigment ◽  
The United States ◽  
Age Related Macular Degeneration ◽  
Therapeutic Interventions ◽  
Oxygen Species ◽  
Ocular Diseases ◽  
Age Related

Aging contributes to the risk of development of ocular diseases including, but not limited to, Age-related Macular Degeneration (AMD) that is a leading cause of blindness in the United States as well as worldwide. Retinal aging, that contributes to AMD pathogenesis, is characterized by accumulation of drusen deposits, alteration in the composition of Bruch’s membrane and extracellular matrix, vascular inflammation and dysregulation, mitochondrial dysfunction, and accumulation of reactive oxygen species (ROS), and subsequent retinal pigment epithelium (RPE) cell senescence. Since there are limited options available for the prophylaxis and treatment of AMD, new therapeutic interventions are constantly being looked into to identify new therapeutic targets for AMD. This review article discusses the potential candidates for AMD therapy and their known mechanisms of cytoprotection in AMD. These target therapeutic candidates include APE/REF-1, MRZ-99030, Ciliary NeuroTrophic Factor (CNTF), RAP1 GTPase, Celecoxib, and SS-31/Elamipretide.

Protein Microarrays: Valuable Tools for Ocular Diseases Research

2020 ◽  
Vol 27 (27) ◽  
pp. 4549-4566
Author(s):  
María Garranzo-Asensio ◽  
Ana Montero-Calle ◽  
Guillermo Solís-Fernández ◽  
Rodrigo Barderas ◽  
Ana Guzman-Aranguez
Keyword(s):  
Molecular Mechanisms ◽  
Protein Microarray ◽  
Unmet Need ◽  
Protein Microarrays ◽  
Specific Protein ◽  
Lifestyle Changes ◽  
Eye Diseases ◽  
Age Related Macular Degeneration ◽  
Ocular Diseases ◽  
Age Related

: The eye is a complex organ comprised of several compartments with exclusive and specialized properties that reflect their diverse functions. Although the prevalence of eye pathologies is increasing, mainly because of its correlation with aging and of generalized lifestyle changes, the pathogenic molecular mechanisms of many common ocular diseases remain poorly understood. Therefore, there is an unmet need to delve into the pathogenesis, diagnosis, and treatment of eye diseases to preserve ocular health and reduce the incidence of visual impairment or blindness. Proteomics analysis stands as a valuable tool for deciphering protein profiles related to specific ocular conditions. In turn, such profiles can lead to real breakthroughs in the fields of ocular science and ophthalmology. Among proteomics techniques, protein microarray technology stands out by providing expanded information using very small volumes of samples. : In this review, we present a brief summary of the main types of protein microarrays and their application for the identification of protein changes in chronic ocular diseases such as dry eye, glaucoma, age-related macular degeneration, or diabetic retinopathy. The validation of these specific protein alterations could provide new biomarkers, disclose eye diseases pathways, and help in the diagnosis and development of novel therapies for eye pathologies.

Nanotechnology for Omics-Based Ocular Drug Delivery

Oncology ◽  
2017 ◽  
pp. 366-381
Author(s):  
Anjali Hirani ◽  
Aditya Grover ◽  
Yong Woo Lee ◽  
Yashwant Pathak ◽  
Vijaykumar Sutariya
Keyword(s):  
Drug Delivery ◽  
Molecular Markers ◽  
Drug Delivery Systems ◽  
Diagnostic Techniques ◽  
Age Related Macular Degeneration ◽  
Ocular Diseases ◽  
Age Related ◽  
Conventional Drug ◽  
Genomics And Proteomics ◽  
Translational Level

Millions of people suffer from ocular diseases that impair vision and can lead to blindness. Advances in genomics and proteomics have revealed a number of different molecular markers specific for different ocular diseases, thereby optimizing the processes of drug development and discovery. Nanotechnology can increase the throughput of data obtained in omics-based studies and allows for more sensitive diagnostic techniques as more efficient drug delivery systems. Biocompatible and biodegradable nanomaterials developed through omics-based research are able to target reported molecular markers for different ocular diseases and offer novel alternatives to conventional drug therapy. In this chapter, the authors review the pathophysiology, current genomic and proteomic information, and current nanomaterial-based therapies of four ocular diseases: glaucoma, uveal melanoma, age-related macular degeneration, and diabetic retinopathy. Omics-based research can be used to elucidate specific genes and proteins and develop novel nanomedicine formulations to prevent, halt, or cure ocular diseases at the transcriptional or translational level.

Sign in / Sign up

Export Citation Format

Share Document